Uncategorized

With oral obesity race underway, all eyes are on Lilly’s Foundayo launch

Published

on

Novo Nordisk’s oral Wegovy has a few months’ head start on Eli Lilly’s newly approved pill. While the Indianapolis pharma has come from behind the Danish rival in the weight loss space before, last time it clearly had the better drug.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version